Coordinated Action on HIV Clinical Research (CA44)
Last updated on 28 May 2025
In brief
The Coordinated Action ‘HIV Clinical Research’ (CA44) adopts a multidisciplinary, person-centred approach to focus on a wide range of HIV research in France and internationally.
This Coordinated Action promotes patient-centred scientific research with a focus on personalised medicine. Its founding principles combine:
- the promotion of young researchers, particularly in low- and middle-income countries (LMICs),
- close collaboration between Europe and LMICs
- cross-cutting groups, in particular with CA41 ‘Host-virus interactions: basic and translational HIV research’ and CA53 ‘Sexually Transmitted Infections’,
- a translational approach.
Activities
The Coordinated Action helps to determine research priorities. It provides scientific facilitation and networking for researchers, and encourages the emergence of promising projects using a bottom-up or top-down approach. These projects will be submitted to national and international calls for proposals, including those of ANRS MIE.
Workgroups
It is structured into two workgroups to cover the current research priorities of people living with HIV:
- Antiretroviral strategies and co-morbidities
- Immunotherapy (in partnership with the Coordinated Action on Host-Virus Interactions: basic and translational HIV research)
Events
The ANRS MIE CA 44 ‘HIV Clinical Research’ is pleased to invite you to its first webinar entitled: ‘Research and innovation: what antiretroviral strategies in LMICs tomorrow?’ which will take place on 27 May 2025 at 5pm by videoconference. This webinar is part of a series of webinars focusing on research in LMICs that will take place throughout 2025.
Agenda:
Moderators: Alain Makinson, Serge Eholié, Maxime Hentzien
- 5pm – 5.20pm: Presentation of the WHO report ‘DTG / TAF toxicity (including Body Weight Gain and cardiometabolic events)’ – Didier Ekouevi and Serge Eholié
- 5.20pm – 5.40pm: Presentation of the WHO report “DRV/r vs ATV/r as a preferred PI option in 2nd line” – Marco Vitoria
- 5.40pm – 6pm: Resistance: state of play and impact on future strategies – Avelin F. Aghokeng
- 6pm – 7pm: Open round table “What research priorities on antiretroviral strategies in PRFIs?” – Didier Ekouevi, Charles Kouanfack (TBC), Françoise Renaud, Marco Vitoria, Roland Landman, Avelin F. Aghokeng, Yazdan Yazdanpanah
Chair and Co-Chair
Alain Makinson
Montpellier University Hospital
Maxime Hentzien
Reims University Hospital
Serge Éholié
Treichville University Hospital, Côte d’Ivoire
Co-Chair CA44 workgroup on Antiretroviral strategies and co-morbidities
Clotilde Allavena (Nantes Hôtel Dieu University Hospital)
Roland Landman (Bichat Hospital)
Chair CA44 workgroup on Immunotherapy (CA44/CA41)
Pierre Delobel (Toulouse University Hospital)
ANRS MIE Coordination
Chloé Duquesnay
(Administrative coordinator)
Manon Ollivier
(Project manager)
Diana Molino
(Project manager)
Marcia Trumeau
(Project manager)
Latest news
Immunotherapy Retreat
Organised jointly by the “Host-Virus Interactions: Basic and Translational HIV Research” coordinated action (CA41) and the “Immunotherapy” clinical research working group of the “HIV clinical research” coordinated action (CA44).
28 May 2025